| Literature DB >> 20600474 |
J Keawcharoen1, M I J Spronken, O Vuong, T M Bestebroer, V J Munster, A D M E Osterhaus, G F Rimmelzwaan, R A M Fouchier.
Abstract
Reverse genetics can be used to produce recombinant influenza A viruses containing virtually every desired combination of hemagglutinin (HA) and neuraminidase (NA) genes using the virus backbone of choice. Here, a repository of plasmids and recombinant viruses representing all contemporary Eurasian HA and NA subtypes, H1-H16 and N1-N9, was established. HA and NA genes were selected based on sequence analyses of influenza virus genes available from public databases. Prototype Eurasian HA and NA genes were cloned in bidirectional reverse genetics plasmids. Recombinant viruses based on the virus backbone of A/PR/8/34, and containing a variety of HA and NA genes were produced in 293T cells. Virus stocks were produced in MDCK cells and embryonated chicken eggs. These plasmids and viruses may be useful for numerous purposes, including influenza virus research projects, vaccination studies, and to serve as reference reagents in diagnostic settings.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20600474 PMCID： PMC2942782 DOI： 10.1016/j.vaccine.2010.06.072
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641